Trial Profile
Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Non-Hodgkin's lymphoma; Solid tumours
- Focus Pharmacodynamics
- 02 May 2016 New trial record